September 23, 2021 Comments Off on New patent for Novartis drug MAYZENT Posted in: Patent Added Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug MAYZENT appeared first on DrugPaten…
September 23, 2021 Comments Off on New patent for NOVO drug OZEMPIC Posted in: Patent Added Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It is available from three suppliers. There are twenty-two patents protecting…
The post New patent for NOVO drug OZEMPIC appeared first on DrugPat…
